NCT05381974View on ClinicalTrials.gov

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

September 15, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Treatment-Resistant Major Depressive Disorder

Interventions

DRUG

Psilocybin

Open-Label

Trial Locations (1)

02129

Athinoula A. Martinos Center for Biomedical Imaging, Charlestown

Sponsors

Collaborators (1)

COMPASS Pathways

All Listed Sponsors

collaborator

COMPASS Pathways

INDUSTRY

lead

Massachusetts General Hospital

OTHER